Home Page ::: Current Neuropharmacology

ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)


Volume 13, 6 Issues, 2015


Download PDF Flyer




Current Neuropharmacology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 113th of 252 in

    Neuroscience

  • 75th of 254 in

    Pharmacology & Pharmacy


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

T.E. Salt


University College London
Institute of Ophthalmology
London EC1V 9EL
UK


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.049
5 - Year: 3.799

New eBook

Neurobiology of Mood Disorders



You can view the contents of this eBook [here] or purchase it [here].

Endorsement(s)

"By providing succinct reviews of recent advances, Current Neuropharmacology will greatly facilitate readers' comprehension of the big picture."

Solomon H. Snyder
Johns Hopkins Univ., USA

Forthcoming Special Issue(s)

The faces of Mania: the legacy of Athanasios Koukopoulos


Guest Editor(s): Sani G, Kotzalidis GD, Girardi P
Tentative Publication Date: April, 2016
Submit Abstract via Email Download Description
Published Special Issue(s)

Role of Antioxidants treatments on Oxidative Stress and Calcium Entry in Neurological Disease: Focus on TRP Channels


Guest Editor(s): Mustafa Nazıroğlu
Download Description
Authors' Comments
I am very satisfied of my collaboration with the journal Current Neuropharmacology and Bentham Science Publishers. I received constant support from the journal manager, when requested, and the production was rapid and efficient. Plus, the quality of the galley proofs was excellent.
With regard to my publication (and the whole special issue), I think it can be of interest for the academia and industry, as it describes a new method that can be used in behavioral neuropharmacology and drug screening. Therefore, the reviews reported in the special issue may attract interest from the researchers working in the drug discovery and drug evaluation fields.

Nicola Simola
Has contributed: Rat Ultrasonic Vocalizations and Behavioral Neuropharmacology the Screening of Drugs to the Study of Disease

Current Neuropharmacology

,

Volume 13

-

Number 3



Nerve Growth Factor: A Focus on Neuroscience and Therapy

; Pp: 294 - 303

Luigi Aloe, Maria Luisa Rocco, Bijorn Omar Balzamino and Alessandra Micera


DOI: 10.2174/1570159X13666150403231920


Abstract Purchase Reprints Eprints Rights & Permissions

  
  



The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option


Antonio Siniscalchi, Antonello Bonci, Nicola Biagio Mercuri, Domenico Pirritano, Aida Squillace, Giovambattista De Sarro and Luca Gallelli


View Abstract

  
  


Alzheimer's disease: Targeting the Cholinergic System


Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva and Fabiola M. Ribeiro


View Abstract

  
  


Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications


Enza Palazzo, Ida Marabese, Vito de Novellis, Francesco Rossi and Sabatino Maione


View Abstract

  
  


Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review


Matrisciano F., Panaccione I., Grayson D.R., Nicoletti F. and Guidotti A.


View Abstract

  
  


Mitochondrial Biology and Neurological Diseases


Siddharth Arun, Lei Liu and Gizem Donmez


View Abstract

  
  


The Involvement of GABAB signaling in the Antipsychotic-like Action of the Novel Orthosteric Agonist of mGlu4 Receptor, LSP4-2022


Monika Wozniak, Francine Acher, Marcin Marciniak, Magdalena Lason-Tyburkiewicz, Piotr Gruca, Mariusz Papp, Andrzej Pilc and Joanna M. Wieronska


View Abstract

  
  


Cognitive Dysfunction in Major Depressive Disorder: a Novel Therapeutic Target?


Beatrice Bortolato, Andre F. Carvalho and Roger S. McIntyre


View Abstract

  
  


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science